Table 1.
Clinical Characteristics of 98 Mediastinal Lymph Node-Negative Patients With Small Cell Lung Cancer (SCLC)
| Clinical Data | Surgery and Chemotherapy | Surgery Alone | p Value |
|---|---|---|---|
| Age | 0.129 | ||
| >70 | 25 (25.51%) | 15 (15.31%) | |
| <70 | 42 (42.86%) | 16 (16.32%) | |
| Sex | 0.081 | ||
| Male | 52 (53.06%) | 24 (24.49%) | |
| Female | 15 (15.31%) | 7 (7.14%) | |
| ECOG PS score | 0.053 | ||
| 0 | 43 (43.87%) | 16 (16.33%) | |
| 1 | 21 (21.43%) | 11 (11.22%) | |
| 2 | 3 (3.00%) | 4 (4.10%) | |
| T stage | 0.132 | ||
| T1 | 32 (32.66%) | 11 (11.22%) | |
| T2 | 35 (35.71%) | 20 (20.41%) | |
| N stage | 0.113 | ||
| N0 | 27 (27.55%) | 15 (15.31%) | |
| N1 | 35 (35.71%) | 21 (21.43%) | |
| Pathological histology | 0.431 | ||
| Small cell carcinoma | 38 (38.77%) | 19 (19.39%) | |
| Combined small cell carcinoma | 29 (29.59%) | 12 (12.25%) | |
| Prophylactic cranial irradiation | 0.065 | ||
| Yes | 18 (18.37%) | 9 (9.18%) | |
| No | 49 (50.00%) | 22 (21.45%) |